CClinicalTrials.gg
Status unknownNCT05419219TaiChi-DTxUpdated Feb 15, 2023

TaiChi-DTx for Treating Long Covid Symptoms

An interventional study of the multi-domain Tai Chi Digital therapy Software Application in Fatigue, Dyspnea and Cognitive Impairment, sponsored by Tim Shi. Status unknown at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-15.

Sponsored by Tim Shi · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The randomized controlled trial will be conducted to evaluate the effectiveness of a Multi-domain Tai Chi Digital Therapy for treating the individuals suffering from the long term COVID-19 syndrome (Long COVID).

Read the detailed description

The randomized controlled trial will be conducted to evaluate the effectiveness of a Multi-domain Tai Chi Digital Therapy for treating the individuals suffering from the long term COVID-19 syndrome (Long COVID).

This intervention will comprise of traditional Tai Chi physical therapy with background music entraining 40 Hz sound wave and respiratory control training. The Multi-domain Tai Chi Digital Therapy will be delivered via a tablet or smart phone to participants for a 4-week therapeutic cycle. Clinical standardized physical tests and self-scored questionnaires will be collected to understand the change in symptoms, including fatigue, dyspnea, and brain fog, as well as absenteeism.

02

Conditions studied

  • Fatigue
  • Dyspnea
  • Cognitive Impairment
  • Muscle Pain

Keywords

  • Long Covid, Tai Chi, Digital Therapeutics
03

In context

Post-Acute COVID-19 Syndrome

520 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 186 are open to participants now.

This study's planned enrollment of 200 is above the median of 60 across 361 interventional studies indexed under Post-Acute COVID-19 Syndrome.

Browse Post-Acute COVID-19 Syndrome studies →

Lead sponsor

Tim Shi is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Clinical diagnosis with SARS-CoV2 infection via PCR during the past 3 to 6 months
  2. Must be Grade 2 and Grade 3 assessed by the Post-COVID-19 Functional Status (PCFS) Scale

Exclusion criteria

Exclusion Criteria:

  1. Admitted in the Intensive Care Unit due to SARS-COV2 infection or any other serve illness
  2. Psychiatric diseases and somatic co-morbidities
  3. COVID-19 infections or co-morbidities started or exacerbated during the same time
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    The Multi-domain Tai Chi Digital Therapy Group

    participants will be provided via a tablet or smart phone the traditional Tai Chi exercise with background music and respiratory control exercise with 18 BPM metronome, and 40 Hz sound stimulation for 4-week therapeutic session.

    Device: the multi-domain Tai Chi Digital therapy Software Application

  • Placebo comparator
    The regular Tai Chi Exercise Group

    participants will be provided by the same way to deliver traditional Tai Chi exercise with plain music background, but without respiratory control exercise or 40 Hz sound stimulation. All participants will receive any other routine care or treatment as usual (TAU).

    Device: the multi-domain Tai Chi Digital therapy Software Application

Interventions

  • Devicethe multi-domain Tai Chi Digital therapy Software Application

    regular Tai Chi exercise, 40 Hz gamma sound stimulation and 18 BPM breath control exercise

06

What researchers measure

Primary outcomes

  1. Change in Physical Activity ability measured by 6-minute walking distance measurement (6MWT)

    The 6-min walk test (6 MWT), a recognized norm by American Thoracic Society, is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-min walk distance (6 MWD) in a 30 meter or 100 foot walkway provides a measure for the integrated response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.

    Time frame: 4 weeks

  2. Overall respiratory relief measured by the Post-COVID-19 Functional Status (PCFS) Scale

    The PCFS scale covers the entire range of functional limitations, including changes in lifestyle, sports, and social activities, and has been widely used as a standard tool to assess recovery after COVID-19 infections (Garout, M.A, 2022). The assignment of a PCFS scale grade concerns the average situation of the past week. The symptoms included in PCFS are dyspnea, pain, fatigue, muscle weakness, memory loss, depression, and anxiety.

    Time frame: 4 weeks

  3. Cognitive impairment improvement measured by the well-validated neuropsychological measurement tests

    Assessment tools including Number Span forward (attention) and backward (working memory) (Becker et al. 2021), and Trail Making Test (processing speed and executive functioning), etc (Douaud, G, et al. 2022).

    Time frame: 4-6 weeks

Secondary outcomes

  1. Change in number of hours/days absent from work related to Long COVID symptoms survey by web-based questionnaires (time frame 6 months after SARS-CoV-2 infection)

    The Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC)

    Time frame: 4-6 weeks

07

Study locations

1 site
  • Tim Shi
    Ellicott City, Maryland 21042, United States
08

References and documents

Publications

  • Castro JP, Kierkegaard M, Zeitelhofer M. A Call to Use the Multicomponent Exercise Tai Chi to Improve Recovery From COVID-19 and Long COVID. Front Public Health. 2022 Feb 28;10:827645. doi: 10.3389/fpubh.2022.827645. eCollection 2022. PubMed 35296042 ↗
  • Gaber TAK, Ashish A, Unsworth A. Persistent post-covid symptoms in healthcare workers. Occup Med (Lond). 2021 Jun 16;71(3):144-146. doi: 10.1093/occmed/kqab043. PubMed 33830208 ↗
  • Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021 Oct 1;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568. PubMed 34643720 ↗
  • Verger A, Kas A, Dudouet P, Goehringer F, Salmon-Ceron D, Guedj E. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience. Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3197-3202. doi: 10.1007/s00259-022-05753-5. Epub 2022 Mar 23. PubMed 35320385 ↗

Individual participant data

Plan to share: Yes — the multi-domain Tai Chi Digital Therapy for Long Covid survivors

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05419219
Lead sponsor
Tim Shi
Responsible party
Tim Shi (Director, GlobalMD Organization Network Corp) — Sponsor-investigator
First posted
Jun 15, 2022
Start date
Jun 1, 2022
Primary completion
May 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Feb 15, 2023

Study contacts

Tim Shi, MD, PhD
principal investigator · GlobalMD Organization

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion